Printer Friendly
The Free Library
21,435,892 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Cancer treatment topic

Reports subtopic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
New Study Identifies the Optimal Dose of Intravenous Vitamin C for Future Anticancer Clinical Trials. May 20, 2013 916
Cancer Vaccine Partnering Terms and Agreements. May 16, 2013 2959
Mouse study shows cancer drug halts accumulation of toxic proteins linked to Parkinson's disease. May 11, 2013 577
Cancer Vaccines: From First-in-Class to Best-in-Class? Apr 9, 2013 5759
Regenerative Medicine Markets. Mar 25, 2013 6938
Testicular Cancer Global Clinical Trials Review, H2, 2012. Mar 21, 2013 1958
Oral Cancer Global Clinical Trials Review, H2, 2012. Mar 21, 2013 2052
Global Radiation Therapy Equipment Industry. Industry overview Mar 20, 2013 5543
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery. Mar 13, 2013 868
Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth. Mar 11, 2013 2650
Research and Markets: Kidney Cancer Drugs - 2012 Global Business Strategic Report Profiles 19 Companies Including Many Key and Niche Players. Report Feb 21, 2013 395
Research and Markets: Global Non-small Cell Lung Cancer Drugs Market 2012-2016. Feb 18, 2013 670
NIH study finds increases in risk of certain leukemias related to treatment. Report Feb 14, 2013 111
Prostate Cancer Patients Treated with Proton Therapy at Loma Linda University Medical Center Show Excellent Quality of Life. Feb 13, 2013 830
Prostate Cancer Patients Report Quality of Life Benefits of Proton Therapy in New Survey. Feb 13, 2013 1071
VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013. Feb 5, 2013 1343
War on cancer. Moss, Ralph Feb 1, 2013 2668
AVEO, Astellas report kidney cancer drug tivozanib matches Bayer/Onyz Nexavar. Feb 1, 2013 236
Diabetes drug could hold promise for treating lung cancer. Jan 30, 2013 583
TechNavio Announces the Publication of Its Research Report - Global Non-Small Cell Lung Cancer Drugs Market 2012-2016. Jan 24, 2013 479
Oral Cancer Global Clinical Trials Review, H2, 2012. Jan 10, 2013 2052
Testicular Cancer Global Clinical Trials Review, H2, 2012. Jan 10, 2013 1956
Research and Markets: Cell Therapy - Technologies, Markets and Companies - 2013 Report. Report Jan 9, 2013 643
ResearchMoz: Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail - Market Research Report. Report Jan 9, 2013 1428
ResearchMoz: Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail - Market Research Report. Report Jan 9, 2013 1432
'Small-molecule Cancer Drug Revenues Will Reach $32.7 Billion in 2016' Predicts New Visiongain Report. Jan 8, 2013 1380
Research and Markets: US Market Changes in the Treatment of Advanced Prostate Cancer 2012. Dec 21, 2012 321
Targeted Cancer Drugs The Launch Landscape to 2018. Dec 12, 2012 1079
Global Radiation Therapy Equipment Industry. Industry overview Dec 11, 2012 5571
Twenty-Four Percent of Surveyed Oncologists Currently Take Part in a Clinical Pathways Program, While 49 Percent Expect to Do So in the Next 12 Months. Dec 10, 2012 638
Aspirin may help older colon cancer patients live longer. Dec 9, 2012 332
UCLA Translational Researchers Report New Combination Therapy That Increases Progression-Free Survival in Hormone-Receptor-Positive Breast Cancer Patients. Dec 5, 2012 864
Changes in Advanced Melanoma Treatment in the USA Reviewed in New The Assessment Group Report Available at MarketPublishers.com. Dec 3, 2012 342
New study supports 15-day fill program for oral cancer medications and again demonstrates lower adherence associated with higher patient out-of-pocket costs. Nov 30, 2012 861
Research and Markets: Breast Cancer - Event Driven Report. Report Nov 29, 2012 291
AVEO and Astellas Announce FDA Acceptance of NDA Filing for Tivozanib for the Treatment of Advanced Renal Cell Carcinoma. Nov 28, 2012 1283
Study reignites controversy over mammograms. Nov 23, 2012 461
Research and Markets: Disease and Therapy Review: Melanoma. Nov 22, 2012 442
Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth. Nov 19, 2012 2216
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery. Nov 19, 2012 878
Cell death offers hope on fertility, cancer treatment. Nov 15, 2012 468
Cancer drug introduces best treatment for multiple sclerosis. Nov 14, 2012 252
Global Radiation Therapy Equipment Market 2011-2015. Industry overview Nov 12, 2012 713
Study Shows Abraxane Extends Survival For Patients With Advanced Pancreatic Cancer. Clinical report Nov 9, 2012 511
MorphoSys and Xencor Report Clinical Data for MOR208/XmAb5574. Report Nov 5, 2012 1341
Research and Markets: Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share. Nov 2, 2012 522
Research and Markets: Global Cervical Cancer Epidemiology and Patient Flow Analysis Report - 2012-2019 Provides Estimates and Forecasts. Clinical report Oct 31, 2012 300
An Expanding Patient Population and the Launches of Several Premium-Priced Branded Agents Will Contribute to the Growth of Russia's Prostate Cancer Drug Market. Oct 29, 2012 626
Multivitamin use may help prevent cancer in middle-aged and older men. Clinical report Oct 18, 2012 653
Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders. Company overview Oct 17, 2012 6327
Sativex Confirms Clinically Relevant Benefits in Multiple Sclerosis Spasticity. Oct 15, 2012 1951
Global Markets for Treatments of Dementia and Movement Disorders -- Focus on Progressive Dementia. Company overview Oct 11, 2012 5752
Global Markets for Treatments of Dementia and Movement Disorders -- Focus on Progressive Dementia with Other Neurological Abnormalities. Company overview Oct 11, 2012 5662
According to Surveyed US Oncologists and Urologists, Patient Share of Sanofi's Jevtana Has Increased Significantly in Third-Line Metastatic Castrate-Resistant Prostate Cancer Setting Today Compared with Six Months Ago. Clinical report Oct 8, 2012 694
Research and Markets: 2012 Report Chinese Markets for Cervical Cancer Treatment Drugs Features Companies such as Yangtze River Pharmaceutical Group and Chengdu Minyi Pharmaceutical Co., Ltd. Oct 4, 2012 296
Prospective Study Shows that Therapy Guided by bioTheranostics' CancerTYPE ID[R] Molecular Test Improves Survival in Cancer of Unknown Primary Patients. Oct 3, 2012 709
Small pox virus shows potential for treating deadly form of breast cancer. Oct 2, 2012 658
Study shows potential for more targeted lung cancer therapies. Brief article Oct 1, 2012 237
Cannabis drug trial in battle on cancer; Scientists' new study will treat patients with advanced tumours. Sep 28, 2012 413
Sensus Healthcare Announces the Publication of a Comprehensive Study on Treating Non-Melanoma Skin Cancer in JAAD. Sep 28, 2012 427
High-Dose Vitamin C Reduces Inflammation in Cancer Patients Study Shows. Sep 25, 2012 620
NBC News Reports that Cannabidiol (CBD) "Turns Off" the Cancer Gene Involved in Metastasis Findings by Scientists at California Pacific Medical Center gives Scientific Support for Cannabis Science Initiatives. Sep 20, 2012 1010
Kinase Inhibitors: Global Markets -- Focus on the U.S. Company overview Sep 6, 2012 5589
Medical Oncologists' Perceptions of Newly Launched Perjeta are Very Promising, Despite Initial Concerns of Increased Cost Associated with Combining Two Premium-Priced Monoclonal Antibodies to Treat HER2-Positive Breast Cancer. Sep 5, 2012 733
Research and Markets: Global Ovarian Cancer Drugs Market 2011-2015: Patent Expiration of Key Drugs Could Pose a Challenge to the Growth of This Market. Sep 4, 2012 364
Kinase Inhibitors: Global Markets -- Focus on Asia. Company overview Sep 4, 2012 5463
Kinase Inhibitors: Global Markets -- Focus on Europe. Company overview Sep 4, 2012 5491
Kinase Inhibitors: Global Markets -- Focus on Emerging Markets. Company overview Sep 4, 2012 5497
The NIH promotes drug repurposing and rescue. Hemphill, Thomas A. Sep 1, 2012 1437
Focus on nanopharmaceuticals: nanopharmaceuticals can create new drugs that are safer and more effective. Smith, James Sep 1, 2012 1870
Research and Markets: Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies. Aug 31, 2012 484
Research and Markets: Cell Therapy - Technologies, Markets and Companies - Updated 2012 Report. Report Aug 31, 2012 641
Million Women Study Supports Correlation between Hormone Replacement Therapy in Treating Menopause Symptoms and Cancer. Aug 30, 2012 1394
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards. Aug 27, 2012 2719
Men with short ring fingers likelier to survive prostate cancer. Aug 16, 2012 357
New drug extends life in men with advanced prostate cancer. Aug 16, 2012 552
Personalized Medicine - A Global Market Overview. Industry overview Aug 16, 2012 4322
Popular diabetes drugs 'up risk of bladder cancer'. Aug 14, 2012 552
Research and Markets: Global Breast Cancer Drugs Market 2011-2015: The Global Breast Cancer Drugs Market to Grow at a CAGR of 1.7 Percent over the Period 2011-2015. Aug 13, 2012 382
Research and Markets: Triple Analysis: Lymphoma, Cancer Vaccines and Protein Kinase Inhibitors - 2012. Aug 10, 2012 509
Research and Markets: Triple Analysis: Lung Cancer, Apoptosis and Protein Kinase Inhibitors - 2012 Out Now. Aug 10, 2012 499
Research and Markets: Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Peptides - 2012 Serves as an External Commercial Advocate for Pharmaceutical Companies' (PPP). Aug 10, 2012 456
New Study Benchmarks Factors Linked to Higher Patient Satisfaction in Cancer Care. Aug 10, 2012 816
Research: High Testosterone Increases Prostate Cancer Risk. Aug 7, 2012 891
Expanding Diagnosed and Drug-Treated Patient Populations Will Contribute to China's Non-Small-Cell Lung Cancer Drug Market Growth. Jul 26, 2012 560
Research and Markets: Disease and Therapy Review: Breast Cancer. Jul 25, 2012 332
Biovest's BiovaxID[R] Lymphoma Vaccine Featured in FierceBiotech Cancer Immunotherapy Special Report. Jul 18, 2012 948
Research and Markets: Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities. Jul 18, 2012 368
Research and Markets: Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise. Jul 18, 2012 469
Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline. Jul 17, 2012 4333
Polaris Oncology System Encourages Smokers to Quit. Jul 17, 2012 618
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities. Jul 17, 2012 1770
'Master switch' drug could treat different cancers. Jul 11, 2012 284
New Report Shows Depth and Breadth of Growing Public Health Threat from Breast Cancer. Report Jul 11, 2012 1132
Nature Publication from Agios Scientists and Co-founder Reinforces Link Between Key Metabolic Enzyme IDH and Cancer. Jul 5, 2012 581
India Biotechnology in India Industry. Company overview Jul 4, 2012 2920
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards. Jul 2, 2012 2124
IVF 'may up breast cancer risk in younger women'. Jun 26, 2012 559
Research and Markets: The Non-small Cell Lung Cancer Drug Market in Indonesia. Jun 20, 2012 565
For the Treatment of Non-Small-Cell Lung Cancer (NSCLC), Three-Quarters of Surveyed U.S. Oncologists Prescribe Pfizer's Xalkori Just 10 Months after the Drug's Launch. Jun 19, 2012 659
Regular CT scans on children 'increases the risk of cancer' STUDY SHOWS HIGHER RISK OF LEUKAEMIA AND BRAIN CANCER. Jun 7, 2012 668
Clinical drug trials challenging, rewarding. Jun 3, 2012 687
Common painkillers tied to lower skin cancer risk: study. May 30, 2012 523
Russia's Colorectal Cancer Drug Market Projected to Grow to More Than $480 Million in 2016. May 30, 2012 585
DNA Sequencing: Emerging Technologies and Applications. Company overview May 30, 2012 6053
MDLinx Survey: Ninety Percent of US Oncologists Report Crucial Cancer Drug Shortage. May 23, 2012 678
New Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More Sensitive than Traditional Method to Detect Minimal Residual Disease in Leukemia. May 16, 2012 886
Commercializing Pancreatic Cancer Drugs: The Faster Route to Consider Your Options and Position of Others. May 10, 2012 5081
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules. May 10, 2012 3163
For the Treatment of Advanced Melanoma, Oncologists Report that Yervoy and Zelboraf have Joined Temodar as the Leading Agents for First-line Therapy. Clinical report May 10, 2012 794
Low oxygen levels 'may drive tumour growth in cancer'. May 4, 2012 600
Estrogen-only HT increases breast cancer risk. Mahoney, Diana May 1, 2012 577
Unions for transfusions: every donation of blood helps to save the lives of up to three people, according to the Australian Red Cross. May 1, 2012 432
Response to wall street journal editorial concerning 5-year cancer survival rates. Apostolides, Anthony Guest editorial May 1, 2012 981
Patients 'miss best cancer treatment' InBrief. Apr 24, 2012 114
In the Treatment of Advanced NSCLC, Two Thirds of Oncologists Agree There is a Higher Unmet Need in Squamous-Cell Patients Compared to Non-Squamous Patients Because of a Reliance on Chemotherapy in the Squamous-Cell Setting. Apr 19, 2012 784
Mayo Clinic Breast Cancer Study Finds New Type of Mutation. Apr 16, 2012 737
For the Treatment of Advanced Non-Small-Cell Lung Cancer, Medical Oncologists Report That They are Rapidly Adopting the ALK-Positive Test into Their Treatment Practices to Identify Appropriate Patients for Xalkori (crizotinib). Apr 16, 2012 681
Estrogen-only HT increases breast cancer risk. Mahoney, Diana Apr 15, 2012 565
Botanical formula shows promise to fight prostate cancer. Apr 11, 2012 370
Over the Next 12 Months, Surveyed U.S. Oncologists Expect Zelboraf to Become More Deeply Ingrained in Medical Practice for the Treatment of BRAF Mutation-Positive Malignant Melanoma. Apr 9, 2012 658
Diamyd Medical: Quarterly Report II 11/12. Apr 4, 2012 1327
Patient Access to Premium-Priced Targeted Cancer Treatments in Brazil and Mexico is Improving, Creating an Opportunity for Developers of EGFR Inhibitors. Apr 4, 2012 686
Docetaxel Dominates First-Line Metastatic Castrate-Resistant Prostate Cancer Treatment, But Total Patient Share of Zytiga and Jevtana Reach Nearly 50 Percent in the Second and Third-Line Settings According to Surveyed Physicians. Clinical report Apr 3, 2012 732
`Intimate relationship` between metastatic breast cancer and arthritis identified. Apr 2, 2012 645
China's Colorectal Cancer Drug Market Expected to Grow to More Than $400 Million in 2016. Apr 2, 2012 581
Cannabis Science Continues Forward with FDA IND Process as Patients Report Successful Cancer Treatments. Apr 2, 2012 707
Infusion Pumps: Technology and Market 2012-2022. Apr 2, 2012 4740
Leading Anti-Cancer Drugs and Associated Market 2012-2022. Apr 2, 2012 5187
New study not encouraging on personalized approach to cancer treatment. Brief article Apr 1, 2012 237
Patients' information needs in affiliated hospitals of Tehran University of medical sciences. Majidi, Moosa; Mahdavi, Hodeiseh; Siamian, Hasan Report Apr 1, 2012 5989
Despite Significant Advances in the Treatment of Chronic Myeloid Leukemia (CML) Over the Last Decade, Hematologist-Oncologists Report High Unmet Need for New Therapies in TKI Treatment-Resistant Patients. Clinical report Mar 29, 2012 701
Older people need better cancer support; NEW REPORT HIGHLIGHTS ISSUES. Mar 26, 2012 451
Research and Markets: Cancer Monoclonal Antibodies Market to 2015. Mar 23, 2012 394
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others. Mar 15, 2012 5237
Antidepressant 'could be promising cancer treatment drug'. Mar 12, 2012 470
Global Personalized Medicine Diagnostics Market Analyzed in New Study Now Available at MarketPublishers.com. Industry overview Mar 12, 2012 511
Research and Markets: Cancer Vaccine Partnering Agreements - Discover the Trends in Cancer Vaccine Dealmaking. Mar 7, 2012 430
"Cancer Drug Market Will Reach $75 Billion in 2012" Visiongain Report Predicts. Mar 2, 2012 502
Genomic Health study shows positive result of new colon cancer RS test. Clinical report Mar 1, 2012 248
Cancer Drug Market To Reach $75 Billion in 2012. Mar 1, 2012 712
Guideline: gynecologic management in breast ca. Smith, Jennie Medical condition overview Mar 1, 2012 780
Nuvilex Reveals Goldman Small Cap Research Cites Groundbreaking Cancer Therapy in Updating Buy Recommendation. Feb 29, 2012 822
Research and Markets: Today 157 Companies Plus Partners Developing 178 FSH Pathway Targeting Drugs in 610 Developmental Projects in Cancer Says 2012 Report. Feb 28, 2012 459
Research and Markets: Today 212 Companies Plus Partners Are Developing 286 Drugs Targeting Ovarian Cancer Says 2012 Report. Feb 28, 2012 413
'Cancer Drug Market Will Reach $75 Billion in 2012' visiongain Report Predicts. Feb 27, 2012 946
Targeted Cancer Drugs Market Analysed by Espicom in New Topical Report Now Available at MarketPublishers.com. Feb 27, 2012 514
Targeted drug extends survival of leukemia patients. Feb 27, 2012 316
Research and Markets: Targeting Cancer Stem Cells: Therapeutic Strategies, Pipeline, Biomarkers and Opportunities 2011. Feb 16, 2012 824
Launch of New Agents with Niche Roles Will Contribute to Drug Market Growth in the Treatment of Non-Muscle-Invasive Bladder Cancer. Feb 14, 2012 714
Osteoporosis: therapeutic interventions. Hudson, Tori Report Feb 1, 2012 8028
Research and Markets: Non-small Cell Lung Cancer Drug Market in South Korea: - Adenocarcinoma, Squamous cell carcinoma and Large cell carcinoma. Jan 13, 2012 410
Research and Markets: Global Lung Cancer Drug Pipeline Capsule - 2012 Report Helps Executives to Keep Abreast of Their Competitors and Understand Their Pipeline Molecules. Jan 10, 2012 404
Medical Marijuana Frontier, Cannabis Science Brand Extracts Successful Cancer Treatments Confirmed as Squamous Cell Carcinoma and Skin Cancer Patients Report Continued Shrinking of Cancer Cells. Jan 6, 2012 1115
Russia's Non-Small-Cell Lung Cancer Drug Market Will Grow to $163 Million in 2015. Dec 14, 2011 493
NHS to be hit by the rising cost of cancer treatment. Dec 12, 2011 373
Cancer survival rates to fall with soaring treatment costs. Dec 12, 2011 207
New Study: Soy May Offer Hope When Conventional Prostate Cancer Treatment Proves Unsuccessful. Report Dec 12, 2011 936
Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservation's 2nd World Congress. Dec 9, 2011 681
Research and Markets: Triple Analysis: Colorectal Cancer, Lymphoma and Peptides. Dec 7, 2011 534
Decision Resources to Release Bladder Cancer Drug Market Forecast Through 2020. Industry overview Dec 7, 2011 423
Global Cancer Therapies Industry. Industry overview Dec 7, 2011 373
Cancer Cells' DNA Repair Disrupted to Increase Radiation Sensitivity. Dec 1, 2011 1017
Research and Markets: Optimizing Treatment for Bone Metastases in Advanced Cancers 2011. Nov 29, 2011 452
Research and Markets: Triple Analysis: Breast Cancer, Melanoma and Peptides - This Report Will Be an Important Part of Creating and Implementing a Market Development Plan for Cancer Drugs. Nov 25, 2011 512
Research and Markets: Apoptosis, Antibodies and Peptides: Cancer Drug Development Strategies. Nov 24, 2011 538
Although Herceptin's Dominance of the Breast Cancer Drug Market in Europe is Threatened by Potential Biosimilar Erosion, the Uptake of Biosimilars May Be Hampered by European Oncologists' and Payers' Perceptions of Biosimilars. Nov 16, 2011 619
Analytical Tool - Antibodies and Peptides in Oncology. Nov 16, 2011 674
The Outlook for Pharmaceuticals in Western Europe. Nov 15, 2011 1488
Team succeeds in targeting cancer cells with near infrared rays. Nov 14, 2011 277
Medical Oncologists Have Rapidly Adopted Yervoy and Zelboraf in All Lines of Therapy for the Treatment of Metastatic Melanoma. Nov 14, 2011 785
Research and Markets: Competitor Analysis: Cancer Vaccines. Nov 7, 2011 337
'Small-Molecule Cancer Drug Revenues Will Reach $27.3bn in 2015' Predicts visiongain Report. Report Nov 3, 2011 2898
For the Treatment of Mutated EGFR Non-Small-Cell Lung Cancer, the Majority of Surveyed European Oncologists Indicate That Tarceva Will Threaten the Market Position of Iressa. Nov 1, 2011 620
Research and Markets: Triple Analysis: Lymphoma, Melanoma and Antibodies. Nov 1, 2011 589
Research and Markets: Lung Cancer Drug Market in India. Oct 28, 2011 461
Research and Markets: Head and Neck Cancer Market in India - a detailed pharmaceutical report. Oct 25, 2011 492
Analytical Tool - Antibodies and Peptides in Oncology. Oct 24, 2011 656
Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011. Oct 24, 2011 1041
Research and Markets: VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011. Oct 21, 2011 545
'World Revenues for Epigenetic Therapies and Technologies Will Reach $2.73bn in 2015' Says visiongain. Oct 20, 2011 1601
Cancer Diagnostic Testing World Markets. Oct 19, 2011 404
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018. Oct 17, 2011 3531
Experts Discuss Emerging Treatments and Advanced Approaches to Radiotherapy Treatments for Lung, Liver, and Breast Cancer. Oct 13, 2011 1401
Faulty gene in the frame for increased risk of prostate cancer. Oct 12, 2011 349
Research and Markets: Cancer Drug Development Strategies in Lymphoma, Vaccines and Peptides. Oct 12, 2011 413
Research and Markets: Lung Cancer Vaccines: 2011 Pipeline, Strategies and Clinical. Clinical report Oct 11, 2011 530
MD Anderson Cancer Center Initiates Orders of IsoRay's Cesium-131 for Intermediate Risk Prostate Cancer Study. Oct 10, 2011 919
Research and Markets: Lung Cancer Therapeutic Antibodies: 2011 Pipeline, Strategies and Clinical Report. Clinical report Oct 10, 2011 659
Research and Markets: Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical. Oct 7, 2011 503
Advances in Imaging Biomarkers: Innovative Technologies, Applications in R&D and Clinical Practice, and Informatics and Regulatory Requirements. Oct 6, 2011 3445
Analytical Tool - Antibodies and Peptides in Oncology. Oct 3, 2011 696
Analytical Tool - Cancer Therapeutic Antibodies. Oct 3, 2011 668
Companion Diagnostics: World Market Outlook 2011-2021. Industry overview Oct 3, 2011 3656
Research and Markets: Disease and Therapy Review: Ovarian Cancer 2011 - Incidence, Prevalence and Mortality and %s for Major Countries Worldwide. Sep 29, 2011 352
Research and Markets: Global Ovarian Cancer Drug Pipeline Capsule - 2011 Report Will Help Executives to Keep A Track of Their Competitors and Understand Their Pipeline Molecules. Sep 27, 2011 404
Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint. Sep 19, 2011 673
New Data Demonstrating Long-term Benefits of FIRMAGON (degarelix) for Advanced Hormone-dependant Prostate Cancer Published in The Journal of Urology. Aug 31, 2011 987
Research and Markets: Novel Approaches to Developing Predictive Diagnostics: A 10% Improvement to Predict Failures before Clinical Trials could Save $100 Million Per Drug. Aug 23, 2011 630
Plexxikon Announces FDA Approval of Zelboraf[TM] (vemurafenib) and Companion Diagnostic for the Treatment of Patients with BRAF Mutation-Positive Metastatic Melanoma. Aug 17, 2011 1722
International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment. Conference notes Aug 10, 2011 700
International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment. Conference notes Aug 10, 2011 706
'If physical exercise were a drug, it would be hitting the headlines' EXERCISE CAN HELP CANCER SURVIVORS, SAYS NEW REPORT. Aug 8, 2011 628
Research and Markets: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market - 2011 Edition Out Now. Aug 8, 2011 404
In the United States, Nearly All Surveyed Physicians Prescribe Pfizer's Sutent and a Significant Majority Prescribe Bayer/Onyx's Nexavar for the Treatment of Renal Cell Carcinoma. Aug 2, 2011 550
ITG Healthcare Market Research Study Finds XGEVA on Track to Be Top-Prescribed Drug for Prevention of SREs in Cancer Patients. Jul 28, 2011 973
Cancer drugs may help treat schizophrenia. Jul 21, 2011 244
NIH-funded study shows reduction in death for men with intermediate-grade prostate cancer. Report Jul 13, 2011 160
Lung cancer patients suffer more in Kirklees; 'Overcoming disease depends on postcode'. Jul 12, 2011 627
MDxHealth's MGMT Test Shown to Be Only Prognostic Factor in Journal of Clinical Oncology Report on Newly Diagnosed Brain Cancer Patients. Jul 11, 2011 837
Research and Markets: 'Advancing Molecular Diagnostics to Personalize Cancer Therapy' report analyzes current and potential world markets. Jul 11, 2011 478
Biovest's Personalized Lymphoma Vaccine Featured in Cancer Research Institute/MD Becker Partners Cancer Immunotherapy Report. Jul 7, 2011 758
China's Gastric Cancer Drug Market Will Grow to $469 Million in 2015. Jul 5, 2011 563
New Comprehensive Drugs and Biotechnology Reviews Recently Published by MarketPublishers.com. Clinical report Jul 5, 2011 482
Study shows prostate cancer screening does not save lives. Jul 1, 2011 342
Cancer symptom severity linked to age, psychiatric history. Otto, M. Alexander Survey Jul 1, 2011 836
Molecular Targeting Maintains the Most Promise as an Early-Stage Approach for Prostate Cancer: companiesandmarkets.com. Jun 30, 2011 425
Combination Therapies Are Becoming the Cancer Treatment of Choice: companiesandmarkets.com. Disease/Disorder overview Jun 28, 2011 440
MDOUTLOOK 4th Annual Quick Polls From ASCO 2011: Report on Clinical Impact of New Developments in Cancer Therapeutics. Jun 21, 2011 831
Almost Half of Surveyed Urologists and Nearly One-Third of Surveyed Oncologists View the Approval of Provenge as a Breakthrough in the Treatment of Prostate Cancer. Jun 14, 2011 720
Report - Cancer Accounts For Half of All Gene Therapy Projects: CompaniesandMarkets.com. Report Jun 6, 2011 400
NIH study finds experimental drug benefits patients with rare type of cancer. Jun 6, 2011 145
Breast Cancer Can Be Prevented by Drug, Study Reveals. Jun 4, 2011 242
University of Maryland Researcher Leads National Study of Novel Approach to Treat Triple-Negative Breast Cancer. Jun 2, 2011 1096
Research and Markets: A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market. May 31, 2011 605
Research and Markets: Triple Analysis: Breast Cancer, Leukemia and Antibodies 2011. May 23, 2011 660
New Report Details the Future of Radiation Medicine. May 23, 2011 658
Research and Markets: Triple Analysis: Leukemia, Pancreatic Cancer and Peptides 2011. May 23, 2011 665
Research and Markets: Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer 2011. May 23, 2011 664
Majority of Physicians Using Herceptin as Key Therapy for Gastric Cancer, But Satisfaction With Treatment Options Remains Low, According to Oncology Tracking Study by GfK HealthCare. Report May 17, 2011 594
ThromboGenics and BioInvent Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Partner Roche. May 16, 2011 1122
ThromboGenics and BioInvent Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Partner Roche. May 16, 2011 1129
BioInvent and ThromboGenics Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Partner Roche. May 16, 2011 959
Reportlinker Adds Molecular Diagnostics Reports Bundle. May 16, 2011 1121
Research and Markets: U.S. Skin Cancer Market - Expensive Low-efficacy Drugs to Give Way to Targeted Therapies and Affordable Generics. May 12, 2011 486
New Healthcare Industry Commercial Insights Recently Published by MarketPublishers.com. May 12, 2011 463
Invasive Tests for Urinary Tract Cancer May Have Minimal Diagnostic Value, Kaiser Permanente Study Cautions. May 5, 2011 949
Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure. Clinical report May 3, 2011 467
Reportlinker Adds Cell Therapy - Technologies, Markets and Companies. May 2, 2011 755
President's Cancer Panel Identifies Urgent Need for Better Understanding of Diverse Populations, Standard of Culturally Appropriate Care. Apr 28, 2011 982
IS MEDICATION OR IS PLACEBO RESPONSE MAKING YOU FEEL BETTER. Apr 27, 2011 1133
Research and Markets: Gastric Cancer Drug Discoveries: What the Future Holds 2011. Apr 21, 2011 385
Research and Markets: Jevtana (Cabazitaxel) - Positive Recommendation in the EU for Metastatic Castration-Resistant Prostate Cancer. Apr 18, 2011 267
New Comprehensive Market Research Reports by GlobalData Now Available at MarketPublishers.com. Apr 15, 2011 448
Patients died after NHS drug refusal; CROSS-BORDER DIVIDE IN CANCER SERVICES 'SEES LIFE EXTENDING HELP DENIED IN WALES'. Apr 6, 2011 390
US Oncologist Surveys and Other New Research Reports by The Assessment Group Published by MarketPublishers.com. Apr 6, 2011 429
Cancer Treatment Breakthrough. Clinical report Apr 4, 2011 638
Reportlinker Adds Cell Therapy - Technologies, Markets and Companies. Apr 4, 2011 754
Research and Markets: Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline - 2011. Mar 30, 2011 571
Research and Markets: Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline - 2011. Mar 30, 2011 489
Research and Markets: Biomarkers in Breast Cancer - 2011 - Comprehensive and Up-to-Date Review. Mar 30, 2011 689
Research and Markets: Triple Analysis: Colorectal Cancer, Antibodies and Peptides. Mar 23, 2011 647
Research and Markets: Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Peptides. Mar 23, 2011 655
Research and Markets: Triple Analysis: Breast Cancer, Colorectal Cancer and Peptides. Mar 23, 2011 655
Surveyed U.S. Oncologists Estimate That 67 Percent of Patients with Advanced Non-Small-Cell Lung Cancer Who Complete First-Line Induction Therapy Receive Maintenance Therapy. Mar 14, 2011 762
Patients Are Willing to Undergo Multiple Tests for New Cancer Treatments. Mar 4, 2011 1137
The More Times a Woman Gives Birth, the Higher Her Risk of Rare but Aggressive 'Triple-Negative' Breast Cancer. Feb 25, 2011 1005
Chemical 'can stop cancer spreading' Hope that finding may lead to new treatments. Feb 22, 2011 444
Kyphon[R] Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients. Clinical report Feb 16, 2011 1710
Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients. Disease/Disorder overview Feb 15, 2011 603
Reportlinker Adds Analytical Tool - Cancer Therapeutic Antibodies. Feb 9, 2011 783
Reportlinker Adds Analytical Tool - Hematological Cancers. Feb 9, 2011 704
Research and Markets: Innovations in the Delivery of Cancer Therapies. Feb 7, 2011 535
New study paves way for better cancer treatment. Feb 5, 2011 286
ICORE Healthcare Releases First Edition of Annual Medical Injectable & Oncology Trend Report. Report Feb 1, 2011 696
Long-term aspirin cut colorectal cancer risk. Worcester, Sharon Feb 1, 2011 1015
Reportlinker Adds The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact. Jan 27, 2011 705
ASTRO Reaffirms Commitment to Quality, Issues Progress Report on Patient Safety Plan. Jan 26, 2011 666
Reportlinker Adds Innovations in the Delivery of Cancer Therapies. Jan 25, 2011 667
Research and Markets: Disease and Therapy Review 2011: Pancreatic Cancer. Jan 24, 2011 329
Drug company links 'may have compromised cancer study in The Lancet'. Jan 21, 2011 413
Reportlinker Adds Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market. Jan 20, 2011 674
Research and Markets: Cervical Cancer Therapeutics Market Is Expected To Grow To $2.2 Billion by 2017 at A Compound Annual Growth Rate (CAGR) Of 5% between 2009 And 2016. Jan 18, 2011 1075
Precision Therapeutics Announces New Study on Multi-Gene Predictors at 2010 San Antonio Breast Cancer Symposium. Jan 17, 2011 498
Research and Markets: Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report. Report Jan 12, 2011 559
Women with advanced breast cancer who were treated with Roche Holding AG's (Basel CHE) Avastin were more likely to develop heart failure than other women, according to an analysis released last week that raised more concerns about the already troubled drug. Jan 10, 2011 346
Avastin raises heart failure risk. Jan 5, 2011 549
PSA test more reliable in men taking prostate-shrinking drug. Dec 18, 2010 718
National Business Group on Health Launches Major Initiative to Address Cancer in the Workplace. Dec 16, 2010 991
Drug Combination Shows Promise for Newly Diagnosed Blood Cancer Patients, Study Finds. Dec 9, 2010 817
Elekta: Six-month Interim Report May - October 2010/11. Dec 8, 2010 682
Better Treatment Adherence and Lower Health Costs for Cancer Patients Using nilotinib. Dec 7, 2010 717
Osteoporosis drug improves survival in cancer patients. Dec 4, 2010 308
The best natural breast cancer fighting combination I've ever seen. Dec 1, 2010 1045
Updates on PET-CT and thyroid cancer. Lin, Frank I.; Iagaru, Andrei Clinical report Dec 1, 2010 3500
New Study Finds Increased Tumor Growth Associated with Increased Delay in Seeking Skin Cancer Treatment. Clinical report Nov 12, 2010 786
Research and Markets: Triple Analysis: Lung Cancer, Angiogenesis and Antibodies. Nov 12, 2010 705
Research and Markets: Breast Cancer - Triple-Negative Breast Cancer Offers a Significant Opportunity to New Market Entrants while Herceptin Dominates the HER-2-Positive Market. Nov 9, 2010 599
LifeSci Advisors Announces Investment Opinion on Genta Incorporated. Nov 9, 2010 1011
Research and Markets: Competitor Analysis on Sphingosine-1-Phosphate (S1P) - S1P Inhibitors & Receptor Have Promise for the Treatment of Cancer. Nov 3, 2010 620
New Deloitte Recap Report Identifies Strategies to Help Reduce Development Times and Increase Success Rates for Cancer Drugs. Report Nov 2, 2010 465
HRT makes breast cancer more deadly: study. Nov 2, 2010 885
Eli Lilly & Co (Indianapolis IN) and Merck KGaA's (Darmstadt DEU) Erbitux helped a group of cancer patients previously thought to be immune to the treatment in a study that contradicts earlier assumptions of the way the drug works in those with a genetic mutation. Nov 1, 2010 349
Research and Markets: Triple Analysis: Colorectal Cancer, Angiogenesis and Cancer Vaccines 2010 Provides Systems, Analytical and Strategic Support. Oct 27, 2010 676
PSA Tests Cut Risk of Prostate Cancer Spreading to the Body. Oct 26, 2010 644
Macmillan has shown the way we need to act to help cancer victims; Veronica German, the Liberal Democrats' health spokeswoman, explains why Wales needs a comprehensive cancer strategy. Disease/Disorder overview Oct 25, 2010 623
Research and Markets: Disease and Therapy Review: Ovarian Cancer - Incidence, Prevalence and Mortality Numbers and Percentages for Major Countries Worldwide. Oct 21, 2010 338
October Research Reports on Drugs and Biotechnology Published by MarketPublishers.com. Oct 19, 2010 459
Low-dose aspirin protects against colorectal ca: benefits of daily use become evident after 1 year, and rise with up to 10 years of use. Worcester, Sharon Oct 15, 2010 595
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study. Oct 13, 2010 1193

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles